Literature DB >> 11296782

Asthma in the elderly--a more severe disease.

K H Lee1, N K Chin, T K Lim.   

Abstract

OBJECTIVE: To determine the severity of asthma in the elderly compared to the younger asthmatics.
DESIGN: Cross-sectional study.
SETTING: University outpatient asthma clinic.
SUBJECTS: Asthmatics seen over a 6 month period in 1997.
RESULTS: There were 154 patients and 16% were elderly (> 65 years) asthmatics. The elderly asthmatics were on significantly more anti-asthmatic medications (2.3 +/- 1.1 vs. 1.6 +/- 0.9, p < 0.001), and their clinical severity was significantly worse than their younger counterparts (Step 2.2 +/- 1.2 vs. 1.7 +/- 1.0, p < 0.001). Near-fatal asthma episodes were also more common in the elderly asthmatics (39% vs 13%, chi 2 test p < 0.01).
CONCLUSIONS: Elderly asthmatics appear to have more severe asthma as evidenced by the increase in near-fatal episodes, and their increased clinical severity.

Entities:  

Mesh:

Year:  2000        PMID: 11296782

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies.

Authors:  Shoroq M Altawalbeh; Carolyn T Thorpe; Janice C Zgibor; Sandra Kane-Gill; Yihuang Kang; Joshua M Thorpe
Journal:  J Am Geriatr Soc       Date:  2016-06-28       Impact factor: 5.562

2.  Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older Adults.

Authors:  Shoroq M Altawalbeh; Carolyn T Thorpe; Janice C Zgibor; Sandra Kane-Gill; Yihuang Kang; Joshua M Thorpe
Journal:  J Manag Care Spec Pharm       Date:  2018-05

3.  The predictors of poorly controlled asthma in elderly.

Authors:  Eui-Kyung Hwang; Hyun Jung Jin; Young-Hee Nam; Yoo Seob Shin; Young-Min Ye; Dong-Ho Nahm; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2012-03-27       Impact factor: 5.764

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.